Do different mechanisms underlie two anxiogenic effects of systemic nicotine?

Behavioural Pharmacology

Volumn 14, Issue 4, 2003, Pages 323-329

  Tucci, Sonia ^a   Genn, R F ^a   Marco, E ^a   File, S E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

5 HT1A receptors; Anxiety; DH E; MLA; Nicotine; Nicotinic receptors; Rat; Social interaction test

Indexed keywords

DIHYDRO BETA ERYTHROIDINE; METHYLLYCACONITINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NICOTINE TARTRATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; NONHUMAN; RAT; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; SOCIAL INTERACTION;

EID: 0042868850     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fbp.0000081782.35927.c6     Document Type: Article

References (41)

1. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur J Pharmacol 264:259-264.
2. 1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 4:399-408.
3. Brioni JD, O'Neill AB, Kim DJ, Buckley MJ, Decker MW, Arneric SP (1994). Anxiolytic-like effects of the novel cholinergic channel activator ABT-418. J Pharmacol Exp Ther 271:353-361.
4. Cheeta S, Kenny PJ, File SE (2000a). Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety. Prog Neuropsychopharmacol Biol Psychiatry 24:1053-1067.
5. 1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration. Eur J Neurosci 12:3797-3802.
6. Cheeta S, Irvine EE, Kenny PJ, File SE (2001). The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology 155:78-85.
7. 3H]methyllycaconitine: a new radioligand for labeling alpha 7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology 38:679-690.
8. Decker MW, Curzon P, Brioni JD, Arneric SP (1994). Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats. Eur J Pharmacol 261:217-222.
9. File SE (1980). The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide like drugs. J Neurosci Methods 2:219-238.
10. File SE (1997). Animal measures of anxiety. In: Crawley J, Gerfen C, McKay R, Rogawski MA, Sibley D, Skolnick P (editors): Current Protocols in Neuroscience. New York: John Wiley & Sons; pp. 8.3.1-8.3.15.
11. File SE, Hyde JR (1978). Can social interaction be used to measure anxiety? Br J Pharmacol 62:19-24.
12. File SE, Seth P (2003). A review of 25 years of the social interaction test. Eur J Pharmacol 463:35-53.
13. File SE, Kenny PJ, Ouagazzal A-M (1998). Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. Behav Neurosci 112:1423-1429.
14. File SE, Fluck E, Leahy A (2001). Nicotine has calming effects on stress-induced mood changes in females, but enhances aggressive mood in males. Int J Neuropsychopharmacol 4:371-376.
15. File SE, Dinnis AK, Heard JE, Irvine EE (2002a). Mood differences between male and female light smokers and nonsmokers. Pharmacol Biochem Behav 72:681-689.
16. File SE, Cheeta S, Irvine EE, Tucci S, Akhtar M (2002b). Conditioned anxiety to nicotine. Psychopharmacology 164:309-317.
17. 1A receptor antagonist. Behav Brain Res 73:337-353.
18. Grottick AJ, Trube G, Corrigall WA, Huwyler J, Malherbe P, Wyler R, Higgins GA (2000). Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. J Pharmacol Exp Ther 294:1112-1119.
19. Hoyer D, Hannon JP, Martin GR (2002). Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533-554.
20. Irvine EE, Cheeta S, File SE (1999). Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav Pharmacol 10:691-697.
21. Irvine EE, Cheeta S, Marshall M, File SE (2001). Different treatment regimens and the development of tolerance to nicotine's anxiogenic effects. Pharmacol Biochem Behav 68:769-776.
22. 1 receptors. Neuropharmacology 39:300-307.
23. Labarca C, Schwarz J, Deshpande P, Schwarz S, Nowak MW, Fonck C et al. (2001). Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proc Natl Acad Sci USA 98:2786-2791.
24. Macallan DR, Lunt GG, Wonnacott S, Swanson KL, Rapoport H, Albuquerque EX (1988). Methyllycaconitine and (+)-anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems. FEBS Lett 226:357-363.
25. Mihailescu S, Drucker-Colin R (2000). Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. Arch Med Res 31:131-144.
26. Mogg AJ, Whiteaker P, McIntosh JM, Marks M, Collins AC, Wonnacott S (2002). Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. J Pharmacol Exp Ther 302:197-204.
27. Netter P, Hennig J, Huwe S, Olbrich R (1998). Personality related effects of nicotine, mode of application, and expectancies on performance, emotional states, and desire for smoking. Psychopharmacology 135:52-62.
28. Newhouse PA, Sunderland T, Narang PK, Mellow AM, Fertig JB, Lawlor BA, Murphy DL (1990). Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease. Psychoneuroendocrinology 15:471-484.
29. Newman MB, Nazian SJ, Sanberg PR, Diamond DM, Shytle RD (2001). Corticosterone-attenuating and anxiolytic properties of mecamylamine in the rat. Prog Neuropsychopharmacol Biol Psychiatry 25:609-620.
30. Newman MB, Manresa JJ, Sanberg PR, Shytle RD (2002). Anxiolytic effects of mecamylamine in two animal models of anxiety. Exp Clin Psychopharmacol 10:18-25.
31. Ouagazzal A-M, Kenny PJ, File SE (1999). Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety. Eur J Neurosci 11:3957-3962.
32. Paylor R, Nguyen M, Crawley JN, Patrick J, Beaudet A, Orr-Urtreger A (1998). Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn Mem 5:302-316.
33. Picciotto MR, Brunzell DH, Caldarone B (2002). Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 13:1097-1106.
34. Rasmussen K, Kallman MJ, Helton DR (1997). Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response. Synapse 27:145-152.
35. Ribeiro EB, Bettiker RL, Bogdanov M, Wurtman RJ (1993). Effects of systemic nicotine on serotonin release in rat brain. Brain Res 621:311-318.
36. Ross SA, Wong JY, Clifford JJ, Kinsella A, Massalas JS, Horne MK, et al. (2000). Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. J Neurosci 20:6431-6441.
37. Sharples GV, Wonnacott S (2001). Neuronal nicotinic receptors. In: Manley S, Barker N (editors): Tocris reviews 19:1-12.
38. Shoaib M, Zubaran C, Stolerman IP (2000). Antagonism of stimulus properties of nicotine by dihydro-β-erythroidine (DHβE) in rats. Psychopharmacology 149:140-146.
39. Stolerman IP, Chandler CJ, Garcha HS, Newton JM (1997). Selective antagonism of behavioural effects of nicotine by dihydro-β-erythroidine in rats. Psychopharmacology 129:390-397.
40. Suemaru K, Araki H, Gomita Y (2000). Involvement of 5-hydroxytryptamine(1A) receptors in nicotine-induced tail tremor in rats. Eur J Pharmacol 408:19-23.
41. Tucci S, Genn RF, File SE (2003). Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors. Neuropharmacology 44:367-373.